EUVIMEDFaigh amach EUVIMED
Open access

The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction

Matthew R Carey iD, Annamaria Ladanyi, Yonatan Mehlman, Rebecca L Molinsky iD, Andrew Eisenberger, Kevin J Clerkin iD, Justin G Aaron, Koji Takeda, Gabriel T Sayer, Nir Uriel, Ryan T Demmer, Paolo C Colombo and 1 more

Clinical Transplantation · 2023

DOI: 10.1111/ctr.14974 ↗

At a glance

Journal article in Clinical Transplantation, 2023. Written by Matthew R Carey and 12 co-authors. Institution: Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA. Major MEDLINE topics: Primary Graft Dysfunction, Heart Transplantation, Heart Failure. Cited 2 times so far (Crossref); 18 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS.

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

Background

Heart transplantation (HT) is the gold standard therapy for advanced heart failure, providing excellent long‐term outcomes. However, postoperative outcomes are limited by bleeding, infections, and primary graft dysfunction (PGD) that contribute to early mortality after HT. HT candidates with pre‐existing hematologic disorders, bleeding, and clotting, may represent a higher risk population. We assessed the short‐ and long‐term outcomes of patients with pre‐existing hematologic disorders undergoing HT. Methods and results Medical records of all adult patients who received HT from January 2010 to December 2019 at our institution were retrospectively reviewed. Hematologic disorders were identified via chart review and adjudicated by a board‐certified hematologist. Inverse probability weighting and multivariable models were used to adjust for potential pretransplant confounders. Four hundred and ninety HT recipients were included, of whom 29 (5.9%) had a hematologic disorder. Hematologic disorders were associated with severe PGD requiring mechanical circulatory support (aOR 3.15 [1.01–9.86]; p = .049), postoperative infections (aOR 2.93 [1.38–6.23]; p = .01), and 3‐year acute cellular rejection (ACR) (≥1R/1B) (aSHR 2.06 [1.09–3.87]; p = .03). There was no difference in in‐hospital mortality (aOR 1.23 [.20–7.58], p = .82) or 3‐year mortality (aHR 1.58 [.49–5.12], p = .44).

Conclusions

Patients with hematologic disorders undergoing HT are at increased risk of severe PGD, postoperative infections, and ACR, while in‐hospital and 3‐year mortality remain unaffected.

Subjects

MeSH terms (MEDLINE)

Primary Graft DysfunctionHeart TransplantationHeart FailureAdultHumansRetrospective StudiesMorbidityRisk FactorsPostoperative Complications

Author keywords

coagulopathyheart transplantationhematologic disordersprimary graft dysfunction

Authors and institutions

  • Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA.
  • Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Hematology/Oncology, Department of Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
  • Division of Infectious Diseases, Department of Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
  • Division of Cardiac, Thoracic & Vascular Surgery, Department of Surgery, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.

ORCID profiles: Matthew R Carey, Rebecca L Molinsky, Kevin J Clerkin

Funding

  • NHLBI NIH HHS

Cite

APA

Carey, M. R., Ladanyi, A., Mehlman, Y., Molinsky, R. L., Eisenberger, A., Clerkin, K. J., Aaron, J. G., Takeda, K., Sayer, G. T., Uriel, N., Demmer, R. T., Colombo, P. C., & Yuzefpolskaya, M. (2023). The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction. Clinical Transplantation. https://doi.org/10.1111/ctr.14974

Vancouver

Carey MR, Ladanyi A, Mehlman Y, Molinsky RL, Eisenberger A, Clerkin KJ, et al. The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction. Clinical Transplantation. 2023. doi:10.1111/ctr.14974

BibTeX
@article{Carey2023,
  author = {Carey, Matthew R and Ladanyi, Annamaria and Mehlman, Yonatan and Molinsky, Rebecca L and Eisenberger, Andrew and Clerkin, Kevin J and Aaron, Justin G and Takeda, Koji and Sayer, Gabriel T and Uriel, Nir and Demmer, Ryan T and Colombo, Paolo C and Yuzefpolskaya, Melana},
  title = {The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.14974}
}
Start for free →